I did say: "I really cannot guess what will be the FDA' position regarding early filing". I can see the arguments (assuming the 24-weeks data hold current profile) but my hunch is the FDA is not that open-minded...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.